Tenaya Therapeutics (TNYA) Shares Outstanding (Weighted Average) (2020 - 2026)

Tenaya Therapeutics' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $216.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 97.4% year-over-year to $216.9 million; the TTM figure through Mar 2026 stood at $216.9 million (up 97.4% YoY), while the FY2025 annual figure was $153.0 million, up 80.34% from the prior year.
• Shares Outstanding (Weighted Average) was $216.9 million for Q1 2026 at Tenaya Therapeutics, up from $153.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $216.9 million in Q1 2026 to a low of $41.3 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $92.8 million across 5 years, with a median of $81.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) soared 3659.14% in 2022, then increased 10.79% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $44.8 million in 2022, then soared by 64.61% to $73.8 million in 2023, then advanced by 14.96% to $84.8 million in 2024, then jumped by 80.34% to $153.0 million in 2025, then soared by 41.78% to $216.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $216.9 million (Q1 2026), $153.0 million (Q4 2025), and $163.3 million (Q3 2025), per Business Quant data.